Dea Shahinas MSc, PhD

Dea Shahinas has over 10 years of experience in protein structural biology and bioinformatics applications to innovate solutions that circumvent antimicrobial resistance. She currently designs single domain antibodies with applications in food safety, animal and human health. Dr. Shahinas has been a principal scientist on combination therapy against various infectious diseases, overcoming vaccine escape events and cataloging microbiome shift events after recurrent infection at AbCelex Technologies Inc and previously at Public Health Ontario. Dr. Shahinas completed her post-doctoral fellowship and Ph.D. at Mount Sinai Hospital and the University of Toronto with a focus on protein biochemistry, molecular microbiology and applied bioinformatics.